MELANOMA STAGE III OR IV

Clinical trials for MELANOMA STAGE III OR IV explained in plain language.

Never miss a new study

Get alerted when new MELANOMA STAGE III OR IV trials appear

Sign up with your email to follow new studies for MELANOMA STAGE III OR IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Melanoma survivors: could immunotherapy harm your heart years later?

Knowledge-focused ENROLLING_BY_INVITATION

This study looks at whether melanoma survivors who received immunotherapy (immune checkpoint inhibitors) may have long-term heart problems, such as increased risk of heart attack. Researchers will invite 60 people who finished treatment 2 to 10+ years ago to undergo heart tests. …

Matched conditions: MELANOMA STAGE III OR IV

Sponsor: Royal Marsden NHS Foundation Trust • Aim: Knowledge-focused

Last updated May 15, 2026 11:57 UTC

MELANOMA STAGE III OR IV

Get alerted when new MELANOMA STAGE III OR IV trials appear

Melanoma survivors: could immunotherapy harm your heart years later?